About KCE Trials
- What is the KCE Trials programme?
- What type of clinical studies does KCE Trials fund?
- Where and by whom are the clinical trials conducted?
- What are our key conditions for data sharing and intellectual property management?
- How does KCE Trials take into account the views of patients?
- How does KCE Trials support clinical research in Belgium?
News and upcoming events
- 2026/10 - Latest news from KCE Trials
- 2026/09 - KCE Trials Symposium - Improving health care efficiency through public funding of clinical research - Dose optimisation - 10 years of KCE Trials - Health and climate change - Registry-based RCTs
- 2026/08 - Latest news from KCE Trials
- 2026/05 - KCE Trials 2026 calls are now open
- 2026/04 Announcement of KCE Trials 2026 calls for proposals - opening 19th May 2026
Funded trials
- Clear Ear: ChoLEsteatomA Recidivism – Evaluation And Recommendations (BeNeFIT24031)
- BRAVE: Same admission cholecystectomy vs initial conservative management in patients with acute cholecystitis and > 5 days of symptoms: a multicentre randomised controlled trial (BeNeFIT24012)
- DoPeNS: A randomised, multicentre, non-inferiority study of oral Doxycycline versus intravenous Penicillin for the treatment of NeuroSyphilis (BeNeFIT24010)
